COVID-19-related medical research: a meta-research and critical appraisal
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Background: Since the start of the COVID-19 outbreak, a large number of COVID-19-related papers have been published. However, concerns about the risk of expedited science have been raised. We aimed at reviewing and categorizing COVID-19-related medical research and to critically appraise peer-reviewed original articles. Methods: The data sources were Pubmed, Cochrane COVID-19 register study, arXiv, medRxiv and bioRxiv, from 01/11/2019 to 01/05/2020. Peer-reviewed and preprints publications related to COVID-19 were included, written in English or Chinese. No limitations were placed on study design. Reviewers screened and categorized studies according to i)publication type,ii)country of publication, and iii) topics covered. Original articles were critically appraised using validated quality assessment tools. Results: Among the 11,452 publications identified, 10,516 met the inclusion criteria, among which 7468 (71.0%) were peer-reviewed articles. Among these, 4190 publications (56.1%) did not include any data or analytics (comprising expert opinion pieces). Overall, the most represented topics were infectious disease (n = 2326, 22.1%), epidemiology (n = 1802, 17.1%), and global health (n = 1602, 15.2%). The top five publishing countries were China (25.8%), United States (22.3%), United Kingdom (8.8%), Italy (8.1%) and India (3.4%). The dynamic of publication showed that the exponential growth of COVID-19 peer-reviewed articles was mainly driven by publications without original data (mean 261.5 articles ± 51.1 per week) as compared with original articles (mean of 69.3 ± 22.3 articles per week). Original articles including patient data accounted for 713 (9.5%) of peer-reviewed studies. A total of 576 original articles (80.8%) showed intermediate to high risk of bias. Last, except for simulation studies that mainly used large-scale open data, the median number of patients enrolled was of 102 (IQR = 37–337). Conclusions: Since the beginning of the COVID-19 pandemic, the majority of research is composed by publications without original data. Peer-reviewed original articles with data showed a high risk of bias and included a limited number of patients. Together, these findings underscore the urgent need to strike a balance between the velocity and quality of research, and to cautiously consider medical information and clinical applicability in a pressing, pandemic context. Systematic review registration: https://osf.io/5zjyx/
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag
Pradhan, P., Pandey, A. K., Mishra, A., Gupta, P., Tripathi, P. K., Menon, M. B., Gomes, J., Vivekanandan, P., & Kundu, B. (2020) · doi:10.1101/2020.01.30.927871 · Cited by 198
RetractedRoB 2: a revised tool for assessing risk of bias in randomised trials
Sterne, J. A. C., Savović, J., Page, M. J., Elbers, R. G., Blencowe, N. S., Boutron, I., Cates, C. J., Cheng, H.-Y., Corbett, M. S., Eldridge, S. M., et al. (2019) · BMJ · doi:10.1136/bmj.l4898 · Cited by 34,787
ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
Sterne, J. A., Hernán, M. A., Reeves, B. C., Savović, J., Berkman, N. D., Viswanathan, M., Henry, D., Altman, D. G., Ansari, M. T., Boutron, I., et al. (2016) · BMJ · doi:10.1136/bmj.i4919 · Cited by 20,329
Stang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies
Whiting, P. F., Rutjes, A. W. S., Westwood, M. E., Mallett, S., Deeks, J. J., Reitsma, J. B., Leeflang, M. M. G., Sterne, J. A. C., Bossuyt, P. M. M., & the QUADAS-2 Group* (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-8-201110180-00009 · Cited by 14,199
Assessing Bias in Studies of Prognostic Factors
Hayden, J. A., van der Windt, D. A., Cartwright, J. L., Côté, P., & Bombardier, C. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-4-201302190-00009 · Cited by 3,287 · cited 3×
“%) studies showed a high risk of bias according to the QUIPS tool.”
MethodInfluentialWynants, L., Van Calster, B., Bonten, M. M., Collins, G. S., Debray, T. P., De Vos, M., Haller, M. C., Heinze, G., Moons, K. G., Riley, R. D., et al. (2020) · doi:10.1101/2020.03.24.20041020 · Cited by 3,070
Development of a critical appraisal tool to assess the quality of cross-sectional studies (AXIS)
Downes, M. J., Brennan, M. L., Williams, H. C., & Dean, R. S. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-011458 · Cited by 2,376 · cited 6×
“The response options for the signalling questions are: (1) Yes (Y); (2) Probably yes (PY); (3) Probably no (PN); (4) No (N); and (5) No information (NI).”
BackgroundMethodResultInfluentialMethodological quality and synthesis of case series and case reports
Murad, M. H., Sultan, S., Haffar, S., & Bazerbachi, F. (2018) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2017-110853 · Cited by 2,242 · cited 3×
“Important nonprotocol interventions are the additional interventions or exposures that: (1) are inconsistent with the trial protocol; (2) trial participants might receive with or after starting their assigned intervention; and (3) are prognostic for the outcome.”
BackgroundArtificial intelligence–enabled rapid diagnosis of patients with COVID-19
Mei, X., Lee, H.-C., Diao, K.-Y., Huang, M., Lin, B., Liu, C., Xie, Z., Ma, Y., Robson, P. M., Chung, M., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0931-3 · Cited by 1,084
Cited by
Bardosh, K., de Figueiredo, A., Gur-Arie, R., Jamrozik, E., Doidge, J., Lemmens, T., Keshavjee, S., Graham, J. E., & Baral, S. (2022) · BMJ Global Health · doi:10.1136/bmjgh-2022-008684 · Cited by 318
Algorithmic fairness in computational medicine
Xu, J., Xiao, Y., Wang, W. H., Ning, Y., Shenkman, E. A., Bian, J., & Wang, F. (2022) · eBioMedicine · doi:10.1016/j.ebiom.2022.104250 · Cited by 170
Haber, N. A., Clarke-Deelder, E., Feller, A., Smith, E. R., Salomon, J. A., MacCormack-Gelles, B., Stone, E. M., Bolster-Foucault, C., Daw, J. R., Hatfield, L. A., et al. (2022) · BMJ Open · doi:10.1136/bmjopen-2021-053820 · Cited by 36
Is biomedical research self-correcting? Modelling insights on the persistence of spurious science
Grimes, D. R. (2024) · Royal Society Open Science · doi:10.1098/rsos.231056 · Cited by 18
“In a short period, much COVID research was subsequently shown to be of low methodological quality, and unsuitable for drawing inferences [1 – 6].”
Background
Metadata
- Authors
- Raynaud, M., Zhang, H., Louis, K., Goutaudier, V., Wang, J., Dubourg, Q., Wei, Y., Demir, Z., Debiais, C., Aubert, O., Bouatou, Y., Lefaucheur, C., Jabre, P., Liu, L., Wang, C., Jouven, X., Reese, P., Empana, J.-P., & Loupy, A.
- Venue
- BMC Medical Research Methodology
- Published
- 2021-01-04
- Volume
- 21
- Issue
- 1
- Pages
- 1-1
- ISSN
- 1471-2288 (ISSN-L)
- OpenAlex
- W3119137505
- Cited by
- 172
- References
- 14
- FWCI
- 28.77
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: COVID-19-related medical research: a meta-research and critical appraisal. https://app.cochat.ai/papers/10.1186/s12874-020-01190-w
- The paper
- Raynaud, M., Zhang, H., Louis, K., Goutaudier, V., Wang, J., Dubourg, Q., Wei, Y., Demir, Z., Debiais, C., Aubert, O., Bouatou, Y., Lefaucheur, C., Jabre, P., Liu, L., Wang, C., Jouven, X., Reese, P., Empana, J.-P., & Loupy, A. (2021). COVID-19-related medical research: a meta-research and critical appraisal. BMC Medical Research Methodology. https://doi.org/10.1186/s12874-020-01190-w
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.